Novo Nordisk A/S
FDA approves Eli Lilly’s tirzepatide for weight loss, paving way for wider use of blockbuster drug
A pharmacist displays boxes of Ozempic, a semaglutide injection drug used for treating type 2 diabetes made by Novo Nordisk, at Rock Canyon Pharmacy in Provo, Utah, on March 29, 2023. George Frey | Reuters The Food and Drug Administration on Wednesday approved Eli Lilly‘s blockbuster drug tirzepatide for weight loss, paving the way for […]
Read More
The Ozempic effect has battered this weight loss stock, but Morgan Stanley says it’s a top pick
Game-changing anti-obesity medications have posed nothing short of an existential crisis for Weight Watchers parent WW International since they arrived on the scene, but CEO Sima Sistani has been confronting this challenge head-on. Despite an 11% dive in the stock Friday, Morgan Stanley said it thinks the company “has gone through an incredible transformation over […]
Read More
Novo Nordisk says 80% of insured U.S. patients taking Wegovy pay less than $25 a month
Still life of Wegovy an injectable prescription weight loss medicine that has helped people with obesity. It should be used with a weight loss plan and physical activity. Michael Siluk | UCG | Getty Images Novo Nordisk on Thursday said 80% of U.S. patients with insurance coverage who take its highly popular weight loss treatment […]
Read More
Eli Lilly says supply of blockbuster diabetes drug Mounjaro has improved in U.S.
A pharmacist displays boxes of Ozempic, a semaglutide injection drug used for treating type 2 diabetes made by Novo Nordisk, at Rock Canyon Pharmacy in Provo, Utah, March 29, 2023. George Frey | Reuters Eli Lilly on Thursday said supply of its blockbuster diabetes drug Mounjaro has improved in the U.S. after months of widespread […]
Read More
Pounds-loss drug Wegovy could get expanded Food and drug administration approval inside of six months, Novo Nordisk states
Even now daily life of Wegovy an injectable prescription fat decline medication that has aided people with being overweight. It should be made use of with a bodyweight loss system and physical activity. Michael Siluk | UCG | Getty Photographs Novo Nordisk said Thursday that its blockbuster bodyweight-reduction drug Wegovy could acquire expanded acceptance from […]
Read More
Eli Lilly results top estimates on Mounjaro strength but slashes full-year profit outlook
Eli Lilly and Company, Pharmaceutical company headquarters in Alcobendas, Madrid, Spain. Cristina Arias | Cover | Getty Images Eli Lilly on Thursday reported third-quarter revenue and adjusted earnings that topped estimates on strong demand for its diabetes drug Mounjaro, but slashed its full-year profit guidance due to charges primarily related to its recent acquisitions. Here’s […]
Read More
Pfizer swings to quarterly loss due to Paxlovid, Covid vaccine write-offs
CFOTO | Future Publishing | Getty Images Pfizer on Tuesday reported a narrower than expected loss for the third quarter as the drugmaker recorded charges largely related to struggles for its Covid antiviral treatment Paxlovid and Covid vaccine. Pfizer said that it recorded a $5.6 billion charge for inventory write-offs in the third quarter due […]
Read More
Here are 5 anti-obesity drug stocks besides Novo Nordisk and Eli Lilly to watch into year-end
Novo Nordisk and Eli Lilly reign over the anti-obesity drug market, and don’t expect this duopoly to end soon, analysts say. But other companies — both big and small — are hoping to grab a piece of this lucrative market. In a research note, Piper Sandler analyst Yasmeen Rahimi said the firm is tracking more […]
Read More
As Ozempic and Wegovy take off, this tech startup just lifted $20 million to deal with body weight loss with facts
Weight loss has usually been major organization, but it can be exploded of late thanks to surging demand for Ozempic, Wegovy and other new diabetes and being overweight prescription drugs. In the initially 50 percent of 2023, sales of Ozempic and Wegovy rose by 58% and 363%, respectively. Which is just after quarterly prescriptions for […]
Read More
CNBC Day by day Open up: Oil deals ahead of Large Tech earnings
Omar Marques | Lightrocket | Getty Photographs This report is from today’s CNBC Day-to-day Open up, our new, international markets publication. CNBC Day-to-day Open up delivers buyers up to speed on almost everything they need to know, no subject where by they are. Like what you see? You can subscribe right here. What you need to […]
Read More